Dr Jonathan Milner, Founder of Abcam plc, is an experienced entrepreneur and investor. He is passionate about supporting UK life science and high-tech start-ups and has provided considerable investment, mentoring and support to over 80 companies including assisting three technology companies to IPO on the London AIM Stock exchange.
Jonathan gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath.
From 1992–95, he was a post-doctoral researcher at Bath, following which he worked at the University of Cambridge in the lab of Professor Tony Kouzarides studying breast cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies, and in 1998 he founded Abcam which is now the world’s leading supplier of antibody-based research reagents.
Jonathan co-founded the Milner Centre for Evolution at the University of Bath with Professor Laurence Hurst in 2018 and the Milner Institute for Therapeutics at the University of Cambridge with Professor Tony Kouzarides in 2015.